BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma
Public ClinicalTrials.gov record NCT00039156. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Phase II Multi-Center Trial of BAY 59-8862 in Patients With Aggressive Refractory Non-Hodgkin's Lymphoma
Study identification
- NCT ID
- NCT00039156
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Theradex
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- ortataxel Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2001
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jul 23, 2008
Started 2002
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | — |
| University of Chicago Cancer Research Center | Chicago | Illinois | 60637-1470 | — |
| Veterans Affairs Medical Center - Shreveport | Shreveport | Louisiana | 71101 | — |
| Louisiana State University Health Sciences Center - Shreveport | Shreveport | Louisiana | 71130-3932 | — |
| Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | — |
| HemOnCare, P.C. | Brooklyn | New York | 11235 | — |
| North Shore University Hospital | Manhasset | New York | 11030 | — |
| State University of New York - Upstate Medical University | Syracuse | New York | 13210 | — |
| Albert Einstein Clinical Cancer Center | The Bronx | New York | 10461 | — |
| New York Medical College | Valhalla | New York | 10595 | — |
| West Clinic | Memphis | Tennessee | 38120 | — |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226-3596 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00039156, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 23, 2008 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00039156 live on ClinicalTrials.gov.